Wayne State research may develop next generation of vaccines against autoimmune diseas

October 27, 2014

DETROIT - A major barrier to treating autoimmune diseases such as Type 1 diabetes is the lack of methods to deliver the therapeutics to specific sites such as the lymph nodes. A researcher in Wayne State University's College of Engineering is working to address this issue with a recently awarded a $475,752 grant from the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health.

Haipeng Liu, Ph.D., assistant professor of chemical engineering and materials science, will seek answers on how to develop "hitchhiking" approaches for drug delivery to targeted sites with the help of the grant, "Design molecular vaccines for Type 1 diabetes." He and his collaborators seek to understand the structure-based rules that govern lymph node targeting at the molecular level that ultimately will aid in designing vaccines against autoimmune diseases.

"A major challenge in developing effective vaccines is how to deliver the vaccine components to antigen-presenting cells in lymphoid organs where the orchestrations of immune cells are initiated," said Liu. "Our goal is to translate a novel 'albumin-hitchhiking' approach to target lymph nodes to molecular Type 1 diabetes vaccines."

Liu says that this approach will simultaneously enhance the efficacy and safety of molecular vaccines via localized vaccine delivery, and regulate the antigen-presenting cells within lymph node microenvironments.

"Our strategy will integrate engineering principles in biomaterials and modify immune functions with a novel role in autoimmunity," added Liu. "The results of these studies will have the potential to catalyze the development of the next generation of vaccines against autoimmune diseases."
-end-
The award number for this NIH grant is 1R56DK103651-01.

Wayne State University is one of the nation's pre-eminent public research universities in an urban setting. Through its multidisciplinary approach to research and education, and its ongoing collaboration with government, industry and other institutions, the university seeks to enhance economic growth and improve the quality of life in the city of Detroit, state of Michigan and throughout the world. For more information about research at Wayne State University, visit http://www.research.wayne.edu.

Wayne State University - Office of the Vice President for Research

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.